Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/54801
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tokgun, Pervin Elvan | - |
dc.contributor.author | Karagenc, Nedim | - |
dc.contributor.author | Karasu, Uğur | - |
dc.contributor.author | Tokgun, Onur | - |
dc.contributor.author | Turel, Samet | - |
dc.contributor.author | Demiray, Aydın | - |
dc.contributor.author | Akca, Hakan | - |
dc.contributor.author | Yüksel, Selçuk | - |
dc.date.accessioned | 2023-11-18T09:29:22Z | - |
dc.date.available | 2023-11-18T09:29:22Z | - |
dc.date.issued | 2023 | - |
dc.identifier.issn | 2618-6500 | - |
dc.identifier.uri | https://doi.org/10.46497/ArchRheumatol.2023.9927 | - |
dc.identifier.uri | https://hdl.handle.net/11499/54801 | - |
dc.description.abstract | Objectives: This study aimed to reveal the genetic background of patients in the two-generation family suffering from rheumatoid arthritis, psoriatic arthropathy pain, scratches, and bruises. Patients and methods: A clinical exome sequencing analysis was performed in 10 individuals in the same family using the Sophia Genetics clinical exome solution kit. Results: A novel V194L mutation in the TMEM173 gene was identified in three members of the family. Two of the family members were treated with the JAK3 inhibitor tofacitinib and recovered completely one month after the treatment. Conclusion: The V194L mutation was reported for the first time in this study, and a positive response was achieved with tofacitinib. © 2023 Turkish League Against Rheumatism. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Turkish League Against Rheumatism (TLAR) | en_US |
dc.relation.ispartof | Archives of Rheumatology | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | STING–associated vasculopathy with onset in infancy | en_US |
dc.subject | tofacitinib | en_US |
dc.subject | V194L mutation | en_US |
dc.subject | adalimumab | en_US |
dc.subject | alanine aminotransferase | en_US |
dc.subject | aspartate aminotransferase | en_US |
dc.subject | colchicine | en_US |
dc.subject | ferritin | en_US |
dc.subject | indometacin | en_US |
dc.subject | Janus kinase 3 inhibitor | en_US |
dc.subject | leflunomide | en_US |
dc.subject | membrane protein | en_US |
dc.subject | methylprednisolone | en_US |
dc.subject | secukinumab | en_US |
dc.subject | tofacitinib | en_US |
dc.subject | transmembrane protein 173 | en_US |
dc.subject | unclassified drug | en_US |
dc.subject | adult | en_US |
dc.subject | arthropathy | en_US |
dc.subject | Article | en_US |
dc.subject | autoinflammatory disease | en_US |
dc.subject | biochemistry | en_US |
dc.subject | child | en_US |
dc.subject | copy number variation | en_US |
dc.subject | DNA extraction | en_US |
dc.subject | female | en_US |
dc.subject | follow up | en_US |
dc.subject | gene frequency | en_US |
dc.subject | gene mutation | en_US |
dc.subject | human | en_US |
dc.subject | infancy | en_US |
dc.subject | prediction | en_US |
dc.subject | prevalence | en_US |
dc.subject | psoriasis | en_US |
dc.subject | rash | en_US |
dc.subject | rheumatoid arthritis | en_US |
dc.subject | swelling | en_US |
dc.subject | thorax radiography | en_US |
dc.subject | vascular disease | en_US |
dc.subject | whole exome sequencing | en_US |
dc.subject | young adult | en_US |
dc.title | Treatment of STING-associated vasculopathy with onset in infancy in patients carrying a novel mutation in the TMEM173 gene with the JAK3-inhibitor tofacitinib | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 461 | en_US |
dc.identifier.endpage | 467 | en_US |
dc.department | Pamukkale University | en_US |
dc.identifier.doi | 10.46497/ArchRheumatol.2023.9927 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 57194019069 | - |
dc.authorscopusid | 14829084900 | - |
dc.authorscopusid | 57193971359 | - |
dc.authorscopusid | 36961438000 | - |
dc.authorscopusid | 55923814400 | - |
dc.authorscopusid | 6503919483 | - |
dc.authorscopusid | 6602146139 | - |
dc.identifier.scopus | 2-s2.0-85172233743 | en_US |
dc.identifier.wos | WOS:001108061700017 | en_US |
dc.institutionauthor | … | - |
item.openairetype | Article | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.fulltext | With Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
CORE Recommender
SCOPUSTM
Citations
1
checked on Nov 23, 2024
Page view(s)
68
checked on Aug 24, 2024
Download(s)
20
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.